Search results
Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium...
FOX 4 Kansas City· 7 hours agoImmunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today ...
Travis Kelce draws 'outlier' take from Chiefs GM after contract extension
ClutchPoints· 44 minutes agoThe Kansas City Chiefs and star tight end Travis Kelce have agreed to a new contract extension that...
Despite trial miss, NRx pushes antidepressant forward with blockbuster hopes in bipolar depression
FierceBiotech· 2 hours agoNRx Pharmaceuticals’ investigational antidepressant has failed to reach statistical significance in...
G7 phase out of coal power must come faster to protect those on the frontline of the climate crisis
Amnesty International· 1 hour agoCommitments put forward by G7 members – which have burnt coal for power for more than a century – to stop using this pollutant by 2035 are simply too late and weakened by unacceptable caveats ...
90 Day Fiance: Liz Woods Set To Join 'The Single Life' Season 5 With New Boyfriend?
TV Season and Spoilers· 1 hour ago90 Day Fiance star Liz is in a new phase of her life. She is no longer with Ed, and things are...
New Jersey seeks fourth round of offshore wind farm proposals as foes push back
WCMH Columbus· 32 minutes agoLONG BEACH TOWNSHIP, N.J. (AP) — New Jersey is seeking a new round of proposals to build wind energy...
Bitterroot Bio kickstarts Phase I trial for cardiovascular disease candidate
Clinical Trials Arena via Yahoo Finance· 1 day agoBitterroot Bio has dosed the first participants in a Phase I trial investigating its candidate for...
CIRM Awards $11.8 Million Grant for Clinical Trial in High-Grade Glioma Including Glioblastoma Using...
WTNH-TV New Haven· 2 hours agoCIRM has awarded the grant to Dr. Noriyuki Kasahara, MD, PhD, at the University of California San Francisco (UCSF) and a group of investigators at California universities to conduct a
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma -...
Benzinga· 7 hours agoNEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell therapies, announced today that the first patient in its Phase
New Jersey seeks fourth round of offshore wind farm proposals as foes push back - WTOP News
WTOP Washington· 32 minutes agoNew Jersey is seeking a new round of proposals to build wind energy farms off its coastline, forging...